RNA sequencing data from patients with heart disease and controls

SND-ID: 2023-80

Creator/Principal investigator(s)

Victoria Rotter Sopasakis - University of Gothenburg, Department of Laboratory Medicine, Institute of Biomedicine orcid

Lillemor Mattsson Hultén - University of Gothenburg, Department of Laboratory Medicine, Institute of Biomedicine orcid

Description

RNA sequencing analysis of atrial cardiac tissue from patients undergoing coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) was performed and compared with atrial cardiac tissue from organ donors and purchased human atrial cardiac RNA.

RNA sequencing analysis was performed at the Genomics Core Facility
at University of Gothenburg, Sweden. All samples (ten controls,
ten CABG patients and ten AVR patients) were quality checked by the
RNA integrity number (RIN) using Tapestation 2200 RNA screenTape
(Agilent Technologies, Santa Clara, CA) and RNA concentration was
measured by NanoDrop (Thermo Fisher, Waltham, MA). RIN values
ranged between 6.6 and 9.0 for all samples. TruSeq Total Stranded RNA
kit with RiboZero (Gold) Sample Preparation Guide (15,031,048 Rev. E)
was used for RNA sample preparation (Illumina, San Diego, CA).
A total of 10 μl (~1 μg) RNA from each sample was used for library
preparation. Directly after depletion, a cleanup step was performed
using 110 ul of the RNAClean XP beads (Beckman Coulter, USA) for each
sample. The fragmentation step was performed for

... Show more..

Language

English

Swedish

Research principal, contributors, and funding

Research principal

University of Gothenburg

Responsible department/unit

Department of Laboratory Medicine, Institute of Biomedicine

Protection and ethical review

Data contains personal data

Yes

Sensitive personal data

Yes

Type of personal data

Pseudonymized human data (RNA)

Code key exists

Yes

Ethics Review

Gothenburg - Ref. 560-12 and 436-15

Method and time period

Unit of analysis

Population

Patients undergoing coronary artery bypass grafting (CABG) or aortic valve replacement (AVR) (experimental group) and organ donors and purchased human RNA (control group).

Study design

Experimental study

Preclinical study

Sampling procedure

Non-probability: Availability
Geographic coverage

Geographic spread

Geographic location: Sweden

Publications

Joakim Sandstedt, Kristina Vukusic, Elham Rekabdar, Göran Dellgren, Anders Jeppsson, Lillemor Mattsson Hultén, Victoria Rotter Sopasakis. Markedly reduced myocardial expression of γ-protocadherins and long non-coding RNAs in patients with heart disease. International Journal of Cardiology, vol 344 (2021), page 149–159.
DOI: https://doi.org/10.1016/j.ijcard.2021.09.046

If you have published anything based on these data, please notify us with a reference to your publication(s). If you are responsible for the catalogue entry, you can update the metadata/data description in DORIS.

Dataset
RNA sequencing data from patients with heart disease and controls

Version 1

Citation

Victoria Rotter Sopasakis, Lillemor Mattsson Hultén. University of Gothenburg (2023). RNA sequencing data from patients with heart disease and controls. Swedish National Data Service. Version 1. https://doi.org/10.5878/e48r-gn02

Download citation

Data format / data structure

Numeric

Creator/Principal investigator(s)

Victoria Rotter Sopasakis - University of Gothenburg, Department of Laboratory Medicine, Institute of Biomedicine orcid

Lillemor Mattsson Hultén - University of Gothenburg, Department of Laboratory Medicine, Institute of Biomedicine orcid

Published: 2023-04-17